Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

摘要: In Brief

12:31 PM PDT · September 23, 2026

Image Credits:

Viswa Colluru / Enveda

Marina Temkin

Enveda secures $311M to bring more nature

正文

In Brief

12:31 PM PDT · September 23, 2026

Image Credits:

Viswa Colluru / Enveda

Marina Temkin

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

, a biotech startup that uses AI to discover new drugs in the natural world, has raised a $311 million Series E at a $2 billion valuation. The fresh funding, which was led by Catalio Capital Management, with participation from Iconiq and others, doubles the valuation Enveda achieved 12 months ago.

The idea behind Enveda is that powerful medicines could be harnessed from plants and microbes, rather than synthesized from scratch in a lab. Viswa Colluru, an early employee of Recursion Pharmaceuticals, founded Enveda in 2019 to speed up the process of discovering these new drugs using AI and other techniques.

While AI hasn’t yet produced any FDA-approved drugs, Enveda is among the wave of companies advancing AI-discovered candidates into human clinical trials. The startup is currently testing several drugs in patients, including one targeting severe skin conditions and another designed to help maintain weight loss after stopping GLP-1s.

Biotech & Health

clinical trials

In Brief

Startups

October 13 – 15

San Francisco

Your next big connection is at Disrupt.

Connect with 10,000+ founders, VCs, operators, and tech leaders. Explore tomorrow’s breakthroughs, hear what’s shaping tech today, and

save up to $200 by Sept. 25 at 11:59 p.m. PT.

BOOK NOW

Newsletters

See More

Subscribe for the industry’s biggest tech news

TechCrunch Daily News

Every weekday and Sunday, you can get the best of TechCrunch’s coverage.

TechCrunch Mobility

TechCrunch Mobility is your destination for transportation news and insight.

Startups Weekly

Startups are the core of TechCrunch, so get our best coverage delivered weekly.

StrictlyVC

Provides movers and shakers with the info they need to start their day.

No newsletters selected.

Subscribe

By submit

来源: TechCrunch AI